Abstract

Most cases of coccidioidomycosis, a fungal infection frequently encountered in the desert southwestern U.S., either require no therapy or respond to fluconazole or itraconazole. However, alternatives are sometimes needed because of refractory disease or medication intolerance. Posaconazole and voriconazole, two newer triazole antifungals, are possible alternatives, but data regarding their use in coccidioidomycosis come only from …

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call